Rimonabant (Acomplia): the first cannabinoid-I receptor blocker for obesity.

Autor: Luque CA, Ehret MJ, Rey JA
Zdroj: P&T: A Peer-Reviewed Journal for Managed Care & Formulary Management; 2007 Apr, Vol. 32 Issue 4, p209-234, 6p
Databáze: Complementary Index
Externí odkaz: